Hikari Power’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Hikari Power’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,500,000	Closed	-$4.25M	–	136
2018 Q3	$4.25M	Buy	2,500,000 +200,000	+9%	+$358K	0.43%	45
2018 Q2	$4M	Buy	2,300,000 +300,000	+15%	+$519K	0.44%	45
2018 Q1	$3.66M	Buy	2,000,000 +100,000	+5%	+$211K	0.43%	40
2017 Q4	$4.24M	Buy	1,900,000 +400,000	+27%	+$994K	0.5%	36
2017 Q3	$4.35M	Buy	1,500,000 +1,000,000	+200%	+$3.41M	0.56%	34
2017 Q2	$2.23M	Buy	500,000 +350,000	+233%	+$1.44M	0.3%	41
2017 Q1	$699K	Buy	+150,000	New	+$870K	0.1%	53

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Hikari Power's SGYP Position: Q4 2018 in Review

Hikari Power sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 2,500,000 shares — an estimated $4.25M sold.

Hikari Power first reported a position in SGYP in Q1 2017 and held it in 7 quarters. The position peaked at $4.35M in Q3 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Hikari Power reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Hikari Power sold 2,500,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $4.25M.
Hikari Power first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2017 and held it in 7 quarters.
Hikari Power's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4.35M in Q3 2017.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Hikari Power's 13F filing for Q4 2018, filed 29 Jan 2019.